To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
FesoterodineThe antimuscarinic Fesoterodine is a drug developed by Schwarz Pharma AG to treat Overactive bladder syndrome.[1] It was recommended for approval by the European Medicines Agency in February 2007, but is not yet available for use.[citation needed] Product highlightReferences
|
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fesoterodine". A list of authors is available in Wikipedia. |
Last viewed
- Bayer MaterialScience to sell polyester resins businesses to Stepan
- First view of hydrogen at the metal-to-metal hydride interface
- A mineral provides the template: peptides assemble into arrays of flat nanotapes on mica surfaces
- BGU researchers invent green alternative to crude oil - Researchers at the Blechner Center have developed a revolutionary process to convert carbon dioxide and hydrogen into a green feed that can be refined into renewable liquid fuels
- Aventis implements SciQuest's Enterprise Substance Manager to establish common logistics infrastructure for research facilities
